Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
EMBO Molecular Medicine|August 14, 2016
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatmentSophia Davidson, Teresa M McCabe, Stefania Crotta, et al.
Scandinavian Journal of Gastroenterology|February 19, 2021
Interferon lambda 4 genotype and pathway in alcoholic hepatitisSidsel Støy, Ewa Terczynska-Dyla, Sanne Skovgård Veidal, et al.
Elife|April 14, 2018
IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmissionJonas Klinkhammer, Daniel Schnepf, Liang Ye, et al.
Science (New York, N.Y.)|June 13, 2020
Type I and III interferons disrupt lung epithelial repair during recovery from viral infectionJack Major, Stefania Crotta, Miriam Llorian, et al.
Medical Microbiology and Immunology|June 8, 2019
Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenzaMichelle M Thomsen, Sofie E Jørgensen, Hans Henrik Gad, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 19, 2018
Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λSophie Jacobs, Fanny Wavreil, Bert Schepens, et al.
The Journal of General Virology|October 22, 2008
The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domainJoao Marques, Jangawar Anwar, Signe Eskildsen-Larsen, et al.
Nature Immunology|March 20, 2019
Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietinLiang Ye, Daniel Schnepf, Jan Becker, et al.
Pageof 9